Peters Femke P, Krishnadath K K, Rygiel Agnieszka M, Curvers Wouter L, Rosmolen Wilda D, Fockens P, Ten Kate Fiebo J W, van Baal Jantine W P M, Bergman Jacques J G H M
Laboratory of Experimental Internal Medicine, Amsterdam, The Netherlands.
Am J Gastroenterol. 2007 Sep;102(9):1853-61. doi: 10.1111/j.1572-0241.2007.01272.x. Epub 2007 May 17.
Malignant transformation of Barrett's mucosa is associated with the accumulation of genetic alterations. Stepwise radical endoscopic resection of the Barrett's segment with early neoplasia is a promising new treatment resulting in complete re-epithelialization of the esophagus with neosquamous epithelium. It is unknown whether radical resection also eradicates genetic abnormalities. The aim of this study was to prospectively evaluate whether genetic abnormalities as found in the Barrett's segment before radical resection are effectively eradicated and absent in the neosquamous epithelium.
Nine patients with early neoplasia who successfully underwent radical resection were included. Immunohistochemistry (IHC) was performed to assess p53 protein overexpression. DNA fluorescent in-situ hybridization was (DNA-FISH) performed for evaluation of numerical abnormalities of chromosomes 1 and 9, and losses of p16 and p53. Immunohistochemistry and DNA-FISH were performed on endoscopic resection specimens of the neoplasia and on follow-up biopsies of the neosquamous epithelium.
DNA-FISH and IHC showed alterations in the pretreatment samples of all patients. All showed aneusomy of chromosome 1 and 9. Loss of p16 and p53 were seen in 6 and 8 patients. IHC showed intense p53 nuclear staining in seven patients. Post-treatment biopsies showed neosquamous epithelium with a normal diploid signal count for all DNA-FISH probes and normal IHC stainings in all patients.
Radical resection of Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities and results in neosquamous epithelium without these genetic abnormalities.
巴雷特黏膜的恶性转化与基因改变的积累有关。对早期肿瘤性病变的巴雷特段进行逐步根治性内镜切除是一种有前景的新治疗方法,可使食管完全重新上皮化,形成新的鳞状上皮。目前尚不清楚根治性切除是否也能消除基因异常。本研究的目的是前瞻性评估根治性切除前在巴雷特段发现的基因异常是否能被有效消除,以及在新的鳞状上皮中是否不存在这些异常。
纳入9例成功接受根治性切除的早期肿瘤患者。采用免疫组织化学(IHC)评估p53蛋白过表达情况。进行DNA荧光原位杂交(DNA-FISH)以评估1号和9号染色体的数目异常以及p16和p53的缺失情况。对肿瘤的内镜切除标本以及新鳞状上皮的随访活检标本进行免疫组织化学和DNA-FISH检测。
DNA-FISH和IHC显示所有患者的预处理样本均有改变。所有患者均显示1号和9号染色体非整倍体。6例和8例患者分别出现p16和p53缺失。免疫组织化学显示7例患者p53核染色强烈。治疗后的活检显示,所有患者的新鳞状上皮对于所有DNA-FISH探针均具有正常的二倍体信号计数,免疫组织化学染色正常。
对早期肿瘤性病变的巴雷特食管进行根治性切除可成功消除先前存在的基因异常,并产生不存在这些基因异常的新鳞状上皮。